PVP Ventures lifts 7Med India stake to 41.23% in ₹127 crore healthcare bet

What's the deal? PVP VenturesDealroom has a profile for this one. Try Dealroom → has completed the second tranche of its acquisition in 7Med IndiaDealroom has a profile for this one. Try Dealroom →, raising its stake to 41.23% of the company's paid-up share capital. The move is part of a ₹127 crore plan to buy a controlling 50.62% stake in the renal care provider.

The specifics: PVP Ventures acquired an additional 4,263 equity shares in this tranche. Its initial investment on November 4, 2025 had already made 7Med India an associate company. The deal is structured through primary and secondary share purchases and funded by cash.

What each side does: 7Med India ranks among the top five organised renal care providers in India, operating a wide network of dialysis services.

Why now? The purchase advances PVP Ventures' strategic pivot into healthcare. Reaching a majority stake is expected to reshape its business profile and future revenue streams.

What changes now? With 41.23% ownership, PVP Ventures is closer to its 50.62% target. It aims to finalise the acquisition in line with the definitive agreements.

The signal: The deal reflects a broader push by investors to consolidate positions in India's growing organised healthcare market, where renal care remains a fragmented but expanding segment.

Read more: Whalesbook

Image credit: Bhakua